
Young adults battling advanced cancer are being left behind when it comes to palliative care, a new study warns. Researchers found that patients aged 18 to 39 are far less likely to receive concurrent palliative care — treatment aimed at managing symptoms and improving quality of life — compared to older adults.
The findings, reported by Oncology Nursing News, highlight a troubling disparity in how cancer care is delivered across age groups. While older patients are routinely offered palliative support alongside curative treatments, younger adults often miss out.
The research analyzed data from cancer patients with advanced stages of the disease. It showed that referral rates for concurrent palliative care were significantly lower for young adults. For instance, patients over 65 were more than twice as likely to receive such care as those under 40.
Oncologists and nurses interviewed for the study cited several reasons. Some assumed younger patients were healthier and could tolerate aggressive treatment without extra support. Others noted that palliative care is still wrongly associated with end-of-life care, not as a complement to active therapy.
Concurrent palliative care has been shown to improve pain management, reduce hospitalizations, and even extend survival in some cancer types. For young adults, who face unique challenges — including fertility concerns, career disruptions, and emotional distress — missing out on this support can be devastating.
“Younger patients often have different needs than older ones,” one researcher noted. “But the system isn’t always set up to meet them.” The study calls for routine integration of palliative assessments for all advanced cancer patients, regardless of age.
Several barriers prevent young adults from accessing concurrent palliative care. A lack of awareness among both patients and doctors is a major factor. Many young patients do not know palliative care is an option during active treatment. Physicians, meanwhile, may hesitate to refer, fearing it signals giving up.
Insurance coverage and hospital policies also play a role. Some institutions still restrict palliative care consults to those with a prognosis of six months or less, which excludes younger patients who may live longer with advanced disease.
Experts argue that changing these policies could close the gap. “We need to shift the mindset,” a palliative care specialist said. “This is about adding life to years, not just years to life.”
What happens next depends on whether healthcare systems adopt age-neutral referral guidelines. Advocacy groups are pushing for updated clinical protocols and better education for oncologists. For young adults with advanced cancer, the clock is ticking.